#EUS guided Transgastric Shunt Obliteration- a novel technique to block shunts for difficult to treat Hepatic Encephalopathy
Supplementary data out now, contains:
👉Video of the technique
👉Case details
👉EEG data
Video link:cdn-links.lww.com/permalink/…#Endohepatology#GITwitter
🔥Hot off the press🔥
Excited 🤩to share our novel technique - EUS guided Transgastric Shunt Occlusion (#ETSO) is out now
An excellent alternative to BRTO for portosystemic shunts, ETSO is
👉 Faster
👉 Less expensive
👉 No need for fluoroscopy suite
doi.org/10.14309/ajg.0000000…
At #DDW2026? Interested in Gastric Varices and Portosystemic Shunts?
Swing by these halls. I shall try to cover the nuances of how #EUS can maage both these complications of portal hypertension! #EndoHepatology
Note the change in time:
10am, W181(ASGE)
EUS guided shunt modulation in cirrhosis
10.40am, W194(AGA)
EUS guided Gastric variceal obliteration
Biliary focus? Check this out:
11.45am, ASGE learning center
Cholangioperitoneoscopy in complex biliary injury
#GITwitter#Endoscopy
Looking forward to moderating tomorrow's @ASGEendoscopy endohepatology SIG-sponsored symposium titled "Endohepatology: Current Updates and Future Directions" alongside @AlyssaChoiMD . This has historically always been a packed room with audience. We have a great lineup tomorrow with outstanding speakers/talks. Hoping to see many of you there! @DDWMeeting@allie_schulman@SahajRathi@BrettEFortuneMD@michaelandrewyu
30th Virginia Liver Symposium and Updates in Gastro by @VCUHealth:
@tariqraseen discussing managing IBS in IBD
📌 IBS like symptoms common in IBD remission
🚫 Exclude ongoing inflammation (FC, CRP)
🧀 Food is most common trigger of IBS: dairy, gluten, wheat, high FODMAP, ☕️, 🍻
💊 Treat with IBS related pain: antispasmodics, peppermint oil
🔍 Recognising IBS-IBD overlap avoids escalation of biologics
@VCU_Liver@AmCollegeGastro@AmerGastroAssn@CrohnsColitisFn
Prof @RichSterlingMD with pro-tips for non-invasive liver disease assessment (NILDA) tools at @VCUHealth Liver Symposium
🩸Blood based NILDA good at ruling out advanced fibrosis (FIB-4, ELF, APRI etc)
👎 However they’re suboptimal at identifying F2-F3
📌 Up to half of those who need Rx (F2-F3) missed if you use FIB-4<1.3 to decide who needs Rx
➕ Use combination of NILDA for assessment (blood based imaging)
📌 in age>65, use FIB-4 threshold of 2 (instead of 1.3)
@VCU_Liver@AmCollegeGastro@AmerGastroAssn@AASLDtweets@EASLedu@INASL_Liver@LiverFellow
#POCUS for HPB medicine/therapeutic endoscopy
Quick and effective focused assessment for key 🔑 clinical questions
A Tweetorial 📹🧵
#GITwitter#endoscopy#ERCP#EUS
5⃣ Is there a bleed? Assessing hepatogastric interface after EUS liver biopsy
Especially if
❗️Cirrhotic liver
❗️Suboptimal coag profile
❗️>1 pass
I personally feel reassured assessing this at 3-4hr mark.
This is where a hematoma would show up
x.com/i/status/1816821793681…
Cirrhosis - Identifying irregular liver outline on ultrasound
I believe all GI units should have at least one bedside ultrasound
Trainees should try to learn #POCUS and use it as an extension of their clinical evaluation
Views #LiverTwitter#GITwitter?
That’s a wrap!
There are multiple other nifty applications of #POCUS in therapeutic endoscopy, but these are the ones I find most useful
Any other uses #GITwitter?
Humbled to be awarded the OP Memorial Rising Star Award at ISGCON 2025. Moments like these rekindle why the journey is worth it.
Grateful to all my mentors, colleagues and patients
🥂 to @AnandVKulkarni2 for winning the SR Nayak Researcher Award
🎗️Award twinning mode on✨